Amgen Cash Flow Overview

AMGN Stock  USD 264.07  1.57  0.59%   
Most accounts from Amgen's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Amgen Valuation and Amgen Correlation analysis.
  
At this time, Amgen's End Period Cash Flow is very stable compared to the past year. As of the 17th of April 2024, Sale Purchase Of Stock is likely to grow to 0.00, while Free Cash Flow is likely to drop about 4.5 B.
Most accounts from Amgen's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Amgen Valuation and Amgen Correlation analysis.
At this time, Amgen's End Period Cash Flow is very stable compared to the past year. As of the 17th of April 2024, Sale Purchase Of Stock is likely to grow to 0.00, while Free Cash Flow is likely to drop about 4.5 B.

Amgen cash flow statement Correlations

0.28-0.070.19-0.060.19-0.760.1-0.090.14-0.050.45-0.10.11-0.21-0.030.09-0.2-0.110.1-0.17
0.28-0.02-0.020.00.37-0.230.12-0.010.660.02-0.18-0.680.040.110.23-0.630.240.750.180.24
-0.07-0.020.30.320.450.250.60.720.230.6-0.41-0.150.360.010.18-0.22-0.330.010.29-0.1
0.19-0.020.3-0.36-0.20.04-0.08-0.39-0.280.010.030.310.67-0.46-0.120.32-0.240.090.89-0.29
-0.060.00.32-0.360.79-0.060.60.460.750.53-0.03-0.56-0.160.320.02-0.470.26-0.47-0.160.16
0.190.370.45-0.20.79-0.140.630.440.840.430.12-0.75-0.050.3-0.09-0.660.19-0.120.040.13
-0.76-0.230.250.04-0.06-0.140.070.05-0.190.09-0.420.24-0.220.490.030.05-0.090.220.2-0.14
0.10.120.6-0.080.60.630.070.590.530.87-0.02-0.310.010.32-0.11-0.230.15-0.190.010.1
-0.09-0.010.72-0.390.460.440.050.590.340.57-0.43-0.32-0.050.160.34-0.38-0.19-0.06-0.410.13
0.140.660.23-0.280.750.84-0.190.530.340.41-0.14-0.87-0.10.310.17-0.770.360.140.00.28
-0.050.020.60.010.530.430.090.870.570.41-0.1-0.160.10.11-0.05-0.130.21-0.170.020.12
0.45-0.18-0.410.03-0.030.12-0.42-0.02-0.43-0.14-0.10.07-0.18-0.08-0.640.210.24-0.440.03-0.27
-0.1-0.68-0.150.31-0.56-0.750.24-0.31-0.32-0.87-0.160.070.11-0.12-0.160.96-0.34-0.250.03-0.21
0.110.040.360.67-0.16-0.05-0.220.01-0.05-0.10.1-0.180.11-0.7-0.20.12-0.020.060.390.17
-0.210.110.01-0.460.320.30.490.320.160.310.11-0.08-0.12-0.70.07-0.130.020.08-0.12-0.17
-0.030.230.18-0.120.02-0.090.03-0.110.340.17-0.05-0.64-0.16-0.20.07-0.23-0.580.33-0.070.1
0.09-0.63-0.220.32-0.47-0.660.05-0.23-0.38-0.77-0.130.210.960.12-0.13-0.23-0.26-0.360.04-0.16
-0.20.24-0.33-0.240.260.19-0.090.15-0.190.360.210.24-0.34-0.020.02-0.58-0.26-0.05-0.140.29
-0.110.750.010.09-0.47-0.120.22-0.19-0.060.14-0.17-0.44-0.250.060.080.33-0.36-0.050.20.11
0.10.180.290.89-0.160.040.20.01-0.410.00.020.030.030.39-0.12-0.070.04-0.140.2-0.37
-0.170.24-0.1-0.290.160.13-0.140.10.130.280.12-0.27-0.210.17-0.170.1-0.160.290.11-0.37
Click cells to compare fundamentals

Amgen Account Relationship Matchups

Amgen cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(66M)(215M)(165M)(742M)491M515.6M
Change In Cash(908M)229M1.7B(360M)3.3B3.5B
Free Cash Flow8.5B9.9B8.4B8.8B7.4B4.5B
Depreciation2.2B3.6B3.4B3.4B4.1B4.3B
Other Non Cash Items(186M)(195M)1.3B1.3B(991M)(941.5M)
Capital Expenditures618M608M880M936M1.1B663.6M
Net Income7.8B7.3B5.9B6.6B6.7B3.4B
End Period Cash Flow6.0B6.3B8.0B7.6B10.9B11.5B
Change To Netincome205M(152M)3.4B485M557.8M379.4M
Investments20.0B(4.7B)733M(6.0B)(2.6B)(2.5B)
Change Receivables(504M)(427M)(429M)(746M)(671.4M)(637.8M)
Net Borrowings(4.5B)2.5B795M6.6B6.0B6.3B
Dividends Paid3.5B3.8B4.0B4.2B(4.6B)(4.3B)

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

  0.8VRTX Vertex Pharmaceuticals Financial Report 6th of May 2024 PairCorr

Moving against Amgen Stock

  0.81RZLT Rezolute TrendingPairCorr
  0.8NVO Novo Nordisk AS Financial Report 2nd of May 2024 PairCorr
  0.74ERAS Erasca Inc Financial Report 20th of May 2024 PairCorr
  0.7CELC Celcuity LLC Financial Report 20th of May 2024 PairCorr
  0.69INDP Indaptus Therapeutics Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Amgen Valuation and Amgen Correlation analysis.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.48
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.